The week in health tech, explained in plain English.Get the free newsletter →
October 27, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

ARPA-H's $62.7M Autonomous AI Bet Raises a Liability Question

By Healthcare Technology News ·

HHS is betting on autonomous AI. On Sept. 9, the department's Advanced Research Projects Agency for Health selected six organizations to build an AI agent that functions as a round-the-clock member of a heart failure patient's care team, managing care between visits and escalating to a clinician only when needed, according to Becker's Hospital Review. The work runs under a four-year, $62.7 million contract.

The project pushes past AI tools that only suggest actions to a clinician. An autonomous agent would act on its own, then loop in a human when a case demands it. That shift is what worries health system leaders. The question they keep returning to is accountability: when an agent makes or delays a clinical decision, who carries the liability, the vendor, the health system, or the clinician overseeing it.

No clear framework exists yet. Malpractice law, FDA oversight, and payer rules were built around human decisions and human-supervised software, not agents that act independently between visits.

Sources

More in Health IT

Health IT

Does Long-Term AI Chatbot Use Cause Isolation? No One Knows

Researchers warn that long-term AI chatbot use may quietly drive social isolation, but a lack of access to usage data from AI companies makes the effect impossible to measure.

Why it matters: Hundreds of millions of people now use AI chatbots daily, yet the long-term mental health consequences remain unmeasured because the data sits locked inside private companies.

Health IT

How AI Aims to Give Physicians Their Attention Back

Health systems are deploying AI documentation and chart-summary tools to cut clerical work and let physicians focus on patients rather than screens.

Why it matters: Clerical burden is a leading driver of physician burnout, and AI that restores face-to-face attention could improve both clinician retention and patient trust.

Health IT

Moderna-Merck mRNA Cancer Vaccine Takes Center Stage at ESMO

Moderna and Merck's personalized mRNA cancer vaccine plus Keytruda headlined a marquee presentation at ESMO 2026 in Madrid, with Amgen's Imdelltra also in focus.

Why it matters: Proof that mRNA can power personalized cancer therapy would reshape oncology pipelines and investment across the industry.